Preclinical study of (212)Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma. Durand-Panteix S, Monteil J, Sage M, Garot A, et al. Br J Cancer 2021 Oct 20. pii: 10.1038/s41416-021-01585.

Read + Share

Amedeo Smart

Independent Medical Education

Durand-Panteix S, Monteil J, Sage M, Garot A, et al. Preclinical study of (212)Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma. Br J Cancer 2021 Oct 20. pii: 10.1038/s41416-021-01585.
PMID: 34671126